Alignment Healthcare Slides After Conference Comments on Stars, Costs, and Ratings Uncertainty
Management cited Star-rating limits, HEI frustration, and a small cost rise.
Already have an account? Sign in.
Management cited Star-rating limits, HEI frustration, and a small cost rise.
Veea and NovaGen signed a term sheet to combine and launch NovaGen Health Networks, a two-stage home health platform. The merger is not closed.
GSK will buy a Chimagen trispecific T-cell engager for multiple myeloma. Phase I trials start in 2027. The deal is worth up to $750 million.
Phase 2 ADDRESS-LC missed statistical significance overall. 21 of 22 measures favored bezisterim; benefits were strongest in severe-symptom subgroups.